- Go to the Sessions
- Event Details
Welcome from the Chairs
Welcome from the Chairs
Welcome to the 3rd Electronic Conference on Pharmaceutical Sciences (ECPS 2014). The Conference covers research in key areas of opportunity and challenge in pharmaceutical sciences, including:
- Neglected Diseases
- New Drugs for AIDS/HIV
- New Drugs for Alzheimer’s Disease
- Hit-to-Lead and Lead-to-Drug Candidates
The e-Conference offers you the opportunity to participate in this international, scholarly conference without the concern or expenditure of travel. In addition, participation is free of charge—both for authors and attendees. Furthermore, the e-conference offers you a rapid and direct exchange with the scientific community, and allows you to receive fast, high quality feedback on your latest work.
The last two electronic conferences in Pharmaceutical Sciences were very successful. We hope you will share our enthusiasm and join us in the 3rd edition of this e-conference.
The 3rd Electronic Conference on Pharmaceutical Sciences will be held at www.sciforum.net/conference/ecps-3, on a platform developed by MDPI to organize electronic conferences.
The e-conference proceedings are sponsored by MDPI and the open access scientific journal, Pharmaceuticals. Accepted papers will be published in the proceedings of this e-conference, and selected papers will also be published in Pharmaceuticals.
We hope you will enjoy this 3rd edition and help make it a productive and enjoyable event.
|Dr. Marcelo Nieto
Chair of the Electronic Conference on Pharmaceutical Sciences
Associate Professor, Department of Pharmaceutical Sciences
School of Pharmacy, Southern Illinois University Edwardsville,
|Dr. Derek J. McPhee
Editor-in-Chief of the Journal Molecules
Founding Editor-in-Chief of the Journal Pharmaceuticals
Director of Chemistry, Amyris, Inc.,
Dr. Marcelo Nieto is a Medicinal Chemist with a vast experience in combinatorial chemistry, natural products and drug design. He has worked in several therapeutic areas such as antiinfectives, opioids and selective estrogen receptor modulators (SERMs). Dr. Nieto received his PhD in chemistry (medicinal chemistry) at the National University of Cordoba, Argentina, followed by a post-doc and a research scientist position at the University of Mississippi where he worked for six years. He moved to SIUE School of Pharmacy in 2006 and he is currently Associate Professor in the Department of Pharmaceutical Sciences. His current research is focussed on the rational design of combinatorial libraries of potential SERMs compounds.Dr. Derek J. McPhee is the Senior Director of Technology Strategy for Amyris, a company delivering high-performance alternatives to petroleum-based products across a wide range of consumer and industry segments. He is also the Editor-in-Chief of the international, open access journal Molecules and the Founding Editor-in-Chief of the journal Pharmaceuticals.
Call for Papers
We are pleased to announce the 3rd Electronic Conference on Pharmaceutical Sciences (ECPS 2014), chaired by Dr. Derek McPhee from Amyris, Inc., USA, and Dr. Marcelo J. Nieto from Southern Illinois University Edwardsville, USA.
- Neglected Diseases
- New Drugs for AIDS/HIV
- New Drugs for Alzheimer Disease
- InterferonsHit-to-lead and Lead-to-drug Candidates
The conference will be completely free of charge—both to attend, and for scholars to upload and present their latest work on the conference platform. There will further be a possibility to submit selected papers to the journal Pharmaceuticals (ISSN 1424-8247; CODEN: PHARH2; https://www.mdpi.com/journal/pharmaceuticals).
ECPS offers you the opportunity to participate in this international, scholarly conference without having the concerns and expense of travelling—all you need is your computer and access to the Internet. We would like to invite you to “attend” this conference by presenting your latest work.
Abstracts (in English) should be submitted by 11 July 2014 online at sciforum.net/conference/ecps-3/call. For accepted abstracts, the full paper can be submitted by 1 August 2014. The conference itself will be held from 15-31 August 2014.
We hope you will be able to join this exciting event and support us in making it a success.
The 3rd Electronic Conference on Pharmaceutical Sciences is organized and sponsored by MDPI, a scholarly open access publisher (https://www.mdpi.com/).
Paper Submission Guidelines
For information about the procedure for submission, peer-review, revision and acceptance of conference proceedings papers, please refer to the section "Instructions for Authors": sciforum.net/conference/ecps-3/instructions
Instructions for Authors
- Full author names
- Affiliations (including full postal address) and authors' e-mail addresses
- Abstract (200-250 words)
- Results and Discussion
Besides their active participation within the forum, authors are also encouraged to submit video presentations. If you are interested in submitting, please contact the conference organizer – firstname.lastname@example.org to get to know more about the procedure. This is an unique way of presenting your paper and discuss it with peers from all over the world. Make a difference and join us for this project!
- Paper Format: A4 paper format, the printing area is 17.5 cm x 26.2 cm. The margins should be 1.75 cm on each side of the paper (top, bottom, left, and right sides).
- Paper Length: The conference proceedings paper should not be longer than 6 pages. The conference manuscript should be as concise as possible.
- Formatting / Style: The paper style of the Journal Pharmaceuticals should be followed. You may download the template file to prepare your paper (see above). The full titles and the cited papers must be given. Reference numbers should be placed in square brackets [ ], and placed before the punctuation; for example  or [1-3], and all the references should be listed separately and as the last section at the end of the manuscript.
- Authors List and Affiliation Format: Authors' full first and last names must be given. Abbreviated middle name can be added. For papers written by various contributors a corresponding author must be designated. The PubMed/MEDLINE format is used for affiliations: complete street address information including city, zip code, state/province, country, and email address should be added. All authors who contributed significantly to the manuscript (including writing a section) should be listed on the first page of the manuscript, below the title of the article. Other parties, who provided only minor contributions, should be listed under Acknowledgments only. A minor contribution might be a discussion with the author, reading through the draft of the manuscript, or performing English corrections.
- Figures, Schemes and Tables: Authors are encouraged to prepare figures and schemes in color. Full color graphics will be published free of charge.
- Figure and schemes must be numbered (Figure 1, Scheme I, Figure 2, Scheme II, etc.) and a explanatory title must be added. Tables should be inserted into the main text, and numbers and titles for all tables supplied. All table columns should have an explanatory heading. Please supply legends for all figures, schemes and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table, a figure or a scheme.
Chairs of the 3rd Electronic Conference on Pharmaceutical Sciences
Dr. Derek J. McPhee
Director of Chemistry, Amyris, Inc.
Dr. Marcelo Nieto
Associate Professor of Pharmaceutical Sciences
School of Pharmacy
Southern Illinois University Edwardsville
Scientific Advisory Committee
Dr. Derek J. McPhee, Amyris, Inc., USA
Dr. Marcelo Nieto, School of Pharmacy, Southern Illinois University Edwardsville, USA
Prof. Dr. Peter A. Leggat, College of Public Health, Medical and Veterinary Sciences, James Cook University, Australia
Prof. Dr. Leonidas A. Phylactou, The Cyprus Institute of Neurology & Genetics, Greece
Prof. Dr. Maurizio Recanatini, University of Bologna, Italy
Dr. Guangshun Wang, University of Nebraska Medical Center, USA
Dr. Howard A. Young, Center for Cancer Research, The National Cancer Institute at Frederick, Frederick, MD, USA
Dr. Shu-Kun Lin, MDPI AG, Basel, Switzerland
Ms. Samanta La Russa, MDPI AG, Basel, Switzerland
A. Neglected Diseases
This section is chaired by: Prof. Dr. Peter A. Leggat, AM, from the College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville Queensland, Australia
The WHO estimates that more than 1 billion people suffer from at least one of the neglected diseases, many of which are neglected tropical diseases. A common element is the need for improved pharmaceuticals and/or better access to these products. This session will seek to highlight recent developments in pharmaceuticals to manage neglected diseases and improving access to these pharmaceuticals. We welcome presentations in these areas as well as in areas where there are evaluations of integrated control programs involving pharmaceutical measures.
Professor Peter Leggat
This section is chaired by: Dr. Howard A. Young, from the Center for Cancer Research, The National Cancer Institute at Frederick, Frederick, MD, USA
Since their discovery over 50 years ago, interferons impact cancer research, autoimmunity, and host responses to infection. Also, a huge commercial market developed for interferons because they became critical for treating hepatitis B and C. However, the use of interferons is changing. This session will seek to highlightrecent developments in the clinical use of these drugs (including Type I, II, and III interferons). In addition, we welcome the presentation and discussion of new preclinical models for interferons in order to offer participants a vision into the future of interferons in the clinic.
Professor Howard Young